T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.32% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CMS Energy
CMS
$22.1B
| $68.8M | 0.02% |
2,349,771
-67,710
| -3% | -$1.88M |
|
752
Exelixis
EXEL
$12.5B
| $68.5M | 0.02% |
19,356,410
+2,548,030
| +15% | +$17.3M |
|
|
ELRC
753
DELISTED
ELECTRO RENT CORP
ELRC
| $68.3M | 0.02% |
3,885,380
-2,900
| -0.1% | -$51.5K |
|
|
SIAL
754
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $68.2M | 0.02% |
730,584
-5,928
| -0.8% | -$554K |
|
|
SSI
755
DELISTED
Stage Stores Inc
SSI
| $68.1M | 0.02% |
2,784,750
+327,870
| +13% | +$6.96M |
|
756
Kimberly-Clark
KMB
$36.5B
| $67.8M | 0.02% |
641,054
+24,928
| +4% | +$2.58M |
|
|
EXXI
757
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $67.7M | 0.02% |
2,873,920
-560,900
| -16% | -$13.2M |
|
758
Acadia Pharmaceuticals
ACAD
$4.98B
| $67.7M | 0.02% |
2,783,520
+186,575
| +7% | +$4.72M |
|
759
Baxter International
BAX
$13.9B
| $67.7M | 0.02% |
1,692,862
-616,183
| -27% | -$23M |
|
|
HOLX
760
DELISTED
Hologic
HOLX
| $67.5M | 0.02% |
3,141,798
+3,048,900
| +3,282% | +$65.8M |
|
761
Healthcare Services Group
HCSG
$1.45B
| $67.3M | 0.02% |
2,316,614
+18,914
| +0.8% | +$519K |
|
|
SPTN
762
DELISTED
SpartanNash
SPTN
| $67.3M | 0.02% |
2,899,850
+248,290
| +9% | +$5.65M |
|
|
FPO
763
DELISTED
First Potomac Realty Trust
FPO
| $67.2M | 0.02% |
5,204,908
+159,441
| +3% | +$2.01M |
|
764
NextEra Energy
NEE
$179B
| $67.1M | 0.02% |
2,806,468
+95,744
| +4% | +$2.17M |
|
765
Terreno Realty
TRNO
$7.51B
| $66.1M | 0.01% |
3,496,149
+27,032
| +0.8% | +$487K |
|
|
KND
766
DELISTED
Kindred Healthcare
KND
| $66.1M | 0.01% |
2,822,080
-693,200
| -20% | -$14.3M |
|
|
PGI
767
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $65.8M | 0.01% |
5,454,800
-6,400
| -0.1% | -$72.7K |
|
768
Dominion Energy
D
$60.2B
| $65.8M | 0.01% |
926,444
+30,606
| +3% | +$2.09M |
|
769
Sempra
SRE
$56.5B
| $65.5M | 0.01% |
1,353,790
+8,446
| +0.6% | +$393K |
|
770
Angi Inc
ANGI
$182M
| $65.5M | 0.01% |
537,353
-61,931
| -10% | -$9.08M |
|
|
GG
771
DELISTED
Goldcorp Inc
GG
| $65.3M | 0.01% |
2,668,348
-217,964
| -8% | -$5.54M |
|
|
AEGN
772
DELISTED
Aegion Corp
AEGN
| $65.3M | 0.01% |
2,580,010
+5,190
| +0.2% | +$115K |
|
773
Ultragenyx Pharmaceutical
RARE
$2.62B
| $65.2M | 0.01% |
+1,390,979
| New | +$71.6M |
|
774
Black Hills Corp
BKH
$5.63B
| $64.9M | 0.01% |
1,126,144
-376
| -0% | -$20.7K |
|
|
DEL
775
DELISTED
Deltic Timber
DEL
| $64.7M | 0.01% |
992,464
+5,114
| +0.5% | +$328K |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.